Researcher.Life Logo

Expert Opinion on Biological Therapy : Impact Factor & More

eISSN: 1744-7682pISSN: 1471-2598

Aims and Scope of Expert Opinion on Biological Therapy

Expert Opinion on Biological Therapy is a monthly peer-reviewed medical journal covering research on all aspects of biological therapy, including gene therapy and gene transfer technologies, therapeutic peptides and proteins, vaccines and antibodies, and cell- and tissue-based therapies. The journal is published by Taylor & Francis and the editor-in-chief is Michael Morse (Duke University Hospital). The journal was established in 2001 and according to the Journal Citation Reports, it has a 2017 impact factor of 3.974. The journal is also indexed in MEDLINE. Less

Key Metrics

CiteScore
7.2
Eigenfactor
0.005 - 0.01
H-Index
96
Impact Factor
< 5
SJR
Q1Pharmacology
SNIP
1.01
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Expert Opinion on Biological Therapy

Expert Opinion on Biological Therapy Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher TAYLOR & FRANCIS LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2001
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Expert Opinion on Biological Therapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Expert Opinion on Biological Therapy

Current outlook on the use of biological agents to improve outcomes in adult secondary hemophagocytic lymphohistiocytosis
  • 29 Jun 2026
  • Expert Opinion on Biological Therapy
Optimizing biologic therapy in psoriasis: dose adjustment, treatment duration, and tapering—an expert perspective
  • 28 Jun 2026
  • Expert Opinion on Biological Therapy
Comparative overview of biosimilar regulatory frameworks and international harmonization trends
  • 20 Jun 2026
  • Expert Opinion on Biological Therapy
Real-world effectiveness of tezepelumab on clinical remission and small airway dysfunction in severe asthma: a 52-week prospective study
  • 4 Jun 2026
  • Expert Opinion on Biological Therapy
Type 2 inflammation and biologics: a twenty-year journey
  • 3 Jun 2026
  • Expert Opinion on Biological Therapy
Biological drugs for the treatment of children with atopic dermatitis
  • 3 Jun 2026
  • Expert Opinion on Biological Therapy
Current outlook on the use of biological agents to improve outcomes in adult secondary hemophagocytic lymphohistiocytosis
  • 29 Jun 2026
  • Expert Opinion on Biological Therapy
Optimizing biologic therapy in psoriasis: dose adjustment, treatment duration, and tapering—an expert perspective
  • 28 Jun 2026
  • Expert Opinion on Biological Therapy
Comparative overview of biosimilar regulatory frameworks and international harmonization trends
  • 20 Jun 2026
  • Expert Opinion on Biological Therapy
Real-world effectiveness of tezepelumab on clinical remission and small airway dysfunction in severe asthma: a 52-week prospective study
  • 4 Jun 2026
  • Expert Opinion on Biological Therapy
Type 2 inflammation and biologics: a twenty-year journey
  • 3 Jun 2026
  • Expert Opinion on Biological Therapy
Biological drugs for the treatment of children with atopic dermatitis
  • 3 Jun 2026
  • Expert Opinion on Biological Therapy

FAQs on Expert Opinion on Biological Therapy